Net sales of $1.68 billion, decrease of 5.6%; organic decline of 6.3% Net income of $60 million; Adjusted EBITDA of $283 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.22 Operating cash flow of

MUMBAI, INDIA, April 16, 2024 – Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, hosted...

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release...

Recognition reinforces Avantor’s commitment to innovation and leadership for biopharma advancement SINGAPORE, March 20, 2024 – Avantor, Inc., a leading global provider of mission-critical...

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, recognized supplier excellence...

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael...